BIO (STOCKS)
Bio-Rad Laboratories, Inc.Class A
$361.190000
-0.890000 (-0.25%)
Prev close: $362.080000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Norman D. Schwartz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,468.56M
- Employees
- 7,700
- P/E (TTM)
- 43.87
- P/B (TTM)
- 1.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$2.62 | $1.77 | +0.8548 | +48.43% |
|
Mar 2026 (Q1)
|
$1.89 | $2.00 | -0.1138 | -5.68% |
|
Dec 2025 (Q4)
|
$2.51 | $2.73 | -0.2175 | -7.97% |
|
Sep 2025 (Q3)
|
$2.26 | $1.95 | +0.3074 | +15.74% |
Financial Statements
| Revenues | $2.59B |
| Benefits Costs and Expenses | $2.24B |
| Cost Of Revenue | $1.25B |
| Costs And Expenses | $2.24B |
| Gross Profit | $1.34B |
| Operating Expenses | $1.29B |
| Selling, General, and Administrative Expenses | $852.20M |
| Research and Development | $265.70M |
| Operating Income/Loss | $53.10M |
| Income/Loss From Continuing Operations After Tax | $222.40M |
| Income/Loss From Continuing Operations Before Tax | $513.10M |
| Income Tax Expense/Benefit | $128.00M |
| Interest Expense, Operating | $48.80M |
| Net Income/Loss | $222.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $222.40M |
| Net Income/Loss Available To Common Stockholders, Basic | $222.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $8.23 |
| Diluted Earnings Per Share | $8.21 |
| Basic Average Shares | 26,534,000 |
| Diluted Average Shares | 26,544,000 |
| Assets | $10.25B |
| Current Assets | $3.02B |
| Inventory | $780.60M |
| Prepaid Expenses | $147.80M |
| Other Current Assets | $2.09B |
| Noncurrent Assets | $7.23B |
| Intangible Assets | $160.00M |
| Other Non-current Assets | $7.07B |
| Liabilities | $3.08B |
| Current Liabilities | $961.30M |
| Accounts Payable | $143.50M |
| Wages | $150.50M |
| Other Current Liabilities | $667.30M |
| Noncurrent Liabilities | $2.12B |
| Long-term Debt | $1.20B |
| Other Non-current Liabilities | $913.10M |
| Equity | $7.17B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.17B |
| Liabilities And Equity | $10.25B |
| Net Cash Flow From Operating Activities | $492.60M |
| Net Cash Flow From Operating Activities, Continuing | $492.60M |
| Net Cash Flow From Investing Activities | -$237.10M |
| Net Cash Flow From Investing Activities, Continuing | -$237.10M |
| Net Cash Flow From Financing Activities | -$120.80M |
| Net Cash Flow From Financing Activities, Continuing | -$120.80M |
| Net Cash Flow | $164.00M |
| Net Cash Flow, Continuing | $134.70M |
| Comprehensive Income/Loss | $151.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $151.50M |
| Other Comprehensive Income/Loss | -$70.90M |
| Other Comprehensive Income/Loss Attributable To Parent | -$117.20M |